Chemoinformaics analysis of 24-Ethyl-5alpha-cholest-7-en-3beta-ol
| Molecular Weight | 414.718 | nRot | 6 |
| Heavy Atom Molecular Weight | 364.318 | nRig | 18 |
| Exact Molecular Weight | 414.386 | nRing | 4 |
| Solubility: LogS | -2.982 | nHRing | 0 |
| Solubility: LogP | 4.125 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 82.5716 |
| nHD | 1 | BPOL | 50.1604 |
| QED | 0.465 |
| Synth | 3.494 |
| Natural Product Likeliness | 0.334 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.537 |
| Pgp-sub | 0.036 |
| HIA | 0.139 |
| CACO-2 | -4.92 |
| MDCK | 0.00000514 |
| BBB | 0.588 |
| PPB | 0.636233 |
| VDSS | 1.276 |
| FU | 0.511101 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.609 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.991 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.019 |
| CYP2d6-inh | 0.347 |
| CYP2d6-sub | 0.921 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.724 |
| CL | 6.586 |
| T12 | 0.114 |
| hERG | 0.425 |
| Ames | 0.006 |
| ROA | 0.261 |
| SkinSen | 0.962 |
| Carcinogencity | 0.067 |
| EI | 0.036 |
| Respiratory | 0.926 |
| NR-Aromatase | 0.018 |
| Antiviral | No |
| Prediction | 0.6863 |